May 6, interim report
January – March 2024
Alligator will host a conference call on Monday at 3:00 p.m. CEST/ 9:00 a.m. EST for investors, analysts and media, where CEO Søren Bregenholt and CFO Marie Svensson will present and comment on the Q1 interim report, which will be followed by a Q&A session. The call will be held in English, and can be accessed through Alligator’s channels on YouTube.
LATEST NEWS
Bulletin from the annual general meeting in Alligator Bioscience AB on 7 May 2024
The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedis …
Alligator Bioscience AB reports financial results for Q1 2024 and provides a business update
Mitazalimab Phase 3 preparations underway following positive top-line results from OPTIMIZE-1 Phase 2 study in pancreatic cancer Positive in …
Change in number of shares and votes in Alligator Bioscience AB
During April 2024, the number of shares and votes in Alligator Bioscience AB (“Alligator”) has increased as a result of the comp …